Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.


CSE:RVV - Post by User

Bullboard Posts
Comment by divot111on Mar 05, 2020 5:21pm
143 Views
Post# 30772517

RE:RE:RE:RE:GREAT RVV DAY NOW LET THE AFTER/BEFORE MARKETS TAKEOVER!

RE:RE:RE:RE:GREAT RVV DAY NOW LET THE AFTER/BEFORE MARKETS TAKEOVER!I almost forgot about that. 40 million warrants to go along with that 40 million share PP as well. Then there is the convertible debenture units from February 5 news. Holy shyte am I glad I sold today given how bloated with shares this is going to be soon. It's actually going to be much more than double yesterdays sharecount without the warrants and covertible debenture units once the .05 cent PP closes. Math always gets in the way with these penny stocks. Tuff to make a buck after the initial hype wears off in my experience. Not always though. There is the odd exception.
Bullboard Posts